Literature DB >> 1906786

Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.

D L Gustafson1, C A Pritsos.   

Abstract

Mitomycin C (MMC) is a bioreductive alkylating agent that is capable of generating oxygen radicals. Porfiromycin (PM) is an analog to MMC that generates oxygen radicals at a significantly lower level than the parent compound. Under aerobic conditions, the toxicity of MMC to EMT6 cells is 2.5-fold that of PM, whereas hypoxically the two are equitoxic. In the present studies, the protective effect of PZ-51 in combination with NAC was assessed against the dose-dependent toxicity of either MMC or PM under both aerobic and hypoxic conditions. Aerobically, the PZ-51 and NAC combination inhibited the toxicity of MMC at concentrations of between 0.25 and 2 microM but had no effect on PM toxicity. Under hypoxic conditions, the PZ-51 and NAC combination had no effect on either MMC or PM toxicity. These findings support a role for oxygen radical generation in the aerobic toxicity of MMC at clinically relevant doses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906786     DOI: 10.1007/bf00685517

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

1.  Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.

Authors:  G R Haenen; B M De Rooij; N P Vermeulen; A Bast
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

2.  Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones.

Authors:  J H Doroshow
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Mitomycin C-enhanced superoxide and hydrogen peroxide formation in rat heart.

Authors:  J H Doroshow
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

4.  Mitomycin C (NSC-26980)--clinical brochure.

Authors:  S K Carter
Journal:  Cancer Chemother Rep 3       Date:  1968-12

5.  Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.

Authors:  C A Pritsos; A C Sartorelli
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

6.  Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.

Authors:  S Rockwell
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

7.  N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes.

Authors:  I A Cotgreave; M S Sandy; M Berggren; P W Moldéus; M T Smith
Journal:  Biochem Pharmacol       Date:  1987-09-15       Impact factor: 5.858

8.  A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase.

Authors:  A Wendel; M Fausel; H Safayhi; G Tiegs; R Otter
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858

9.  Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.

Authors:  K A Kennedy; S Rockwell; A C Sartorelli
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.

Authors:  A M Rauth; J K Mohindra; I F Tannock
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.